Secondary (AA) Amyloidosis

Clinical trial pipeline · Data from ClinicalTrials.gov

See which Secondary (AA) Amyloidosis trials you may qualify for

Total trials

Actively recruiting

Phase 3 trials

Completed

Trial phase breakdown

Trial status

All recent trials (2 shown)

CompletedPhase 2

NCT01677286

Safety and Effect of Doxycycline in Patients With Amyloidosis

The tetracycline antibiotic doxycycline disrupts A beta amyloid fibrils (AB) in Alzheimer's disease, transthyretin (ATTR) amyloid fibrils in familial amyloidoti…

United States25 participantsStarted 2012-07

Treatment: Doxycycline 100 mg po bid x 12 months

CompletedPhase 2/3

NCT00035334

Study of the Safety and Efficacy of NC-503 in Secondary (AA) Amyloidosis

The main objective of this study is to evaluate the safety and efficacy of NC-503 compared to placebo in patients with secondary (AA) amyloidosis using a compos…

United States, Finland150 participantsStarted 2001-10

Treatment: NC-503 (Anti-amyloidotic (AA) Agent)